Mioduchoski, FNP-BC, a board-certified Family Nurse Practitioner with experience in wellness medicine, peptide therapy, hormone optimization, regenerative medicine, and medical weight loss
Specifically, high attained dose was associated with lower: all-cause mortality (RR = 0.42, P 25% group, with a mean patient-level change of 0.2% versus 0.8% relative to the pre-treatment baseline measurement ( P 25% weight loss group (126 mmHg versus 13 mmHg, P 25% weight loss group (75.4 mmHg versus 78.0 mmHg) and progressively larger patient-level declines relative to baseline across the different weight loss strata ( P = 0.002
While often lumped together, they have distinct effects and are FDA-approved for different purposes
To conclude, IGF-1 may improve muscle development by enhancing the rate at which generic stem cells are transformed into muscle cells